LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-5.18 Cr | ₹-4.50 Cr | ₹-2.56 Cr | ₹-5.75 Cr | ₹-38 Cr |
What is the latest Cash Flow from Financing Activities ratio of LINCOLN PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-5.18 Cr |
Mar2023 | ₹-4.50 Cr |
Mar2022 | ₹-2.56 Cr |
Mar2021 | ₹-5.75 Cr |
Mar2020 | ₹-38 Cr |
How is Cash Flow from Financing Activities of LINCOLN PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.18 Cr | Negative | |
Mar2023 | ₹-4.50 Cr | Negative | |
Mar2022 | ₹-2.56 Cr | Negative | |
Mar2021 | ₹-5.75 Cr | Negative | |
Mar2020 | ₹-38 Cr | - |
Compare Cash Flow from Financing Activities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,127.8 Cr | -3.7% | -6.4% | -7.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.7% |
-6.4% |
-7.3% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses